Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.
(Q51471902)
scientific article published on 4 May 2007
scientific article published on 4 May 2007
Language: